Zenas BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Zenas BioPharma, Inc. (ZBIO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $139.39 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $139.39M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $68.89M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $243.98M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $98.13M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-06-30 | $139.39M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $68.89M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $243.98M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $98.13M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.51M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.10M 10-Q · filed 2025-11-12 |